Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Nodular lymphocyte predominant Hodgkin lymphoma. An immunophenotypic reappraisal based on a single-institution experience.

Uherova P, Valdez R, Ross CW, Schnitzer B, Finn WG.

Am J Clin Pathol. 2003 Feb;119(2):192-8.

PMID:
12579988
2.

Nodular lymphocyte predominant Hodgkin lymphoma.

Lee AI, LaCasce AS.

Oncologist. 2009 Jul;14(7):739-51. doi: 10.1634/theoncologist.2009-0099. Epub 2009 Jul 15. Review.

3.

Beyond the lymphocyte predominant cell: CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma.

Rahemtullah A, Harris NL, Dorn ME, Preffer FI, Hasserjian RP.

Leuk Lymphoma. 2008 Oct;49(10):1870-8. doi: 10.1080/10428190802308728. Review.

PMID:
18949610
4.

Nodular lymphocyte-predominant hodgkin lymphoma.

Tsai HK, Mauch PM.

Semin Radiat Oncol. 2007 Jul;17(3):184-9. Review.

PMID:
17591565
5.

Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.

Gloghini A, Bosco A, Ponzoni M, Spina M, Carbone A.

Expert Rev Hematol. 2015 Apr;8(2):217-23. doi: 10.1586/17474086.2015.991388. Epub 2014 Dec 9. Review.

PMID:
25487651
6.

Modern management of lymphocyte-predominant Hodgkin lymphoma.

Xing KH, Savage KJ.

Br J Haematol. 2013 May;161(3):316-29. doi: 10.1111/bjh.12244. Epub 2013 Feb 8. Review.

PMID:
23398605
7.

Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma.

Nogová L, Rudiger T, Engert A.

Hematology Am Soc Hematol Educ Program. 2006:266-72. Review.

PMID:
17124071
8.

A histogenetic model for Hodgkin's lymphoma development. A Proposal based on immunophenotypic markers.

Carbone A.

Adv Clin Path. 2000 Oct;4(4):192-4. Review. No abstract available.

PMID:
11436157
9.

Treatment of nodular lymphocyte-predominant Hodgkin lymphoma-"do no harm".

Bartlett NL.

Clin Adv Hematol Oncol. 2013 Jun;11(6):385-7. Review. No abstract available.

PMID:
24472810

Supplemental Content

Support Center